HÆGÐATREGÐA HJÁ FULLORÐNUM

 

Inngangur

Hgatrega er algeng og m skilgreina sem hgalosun sjaldnar en 3svar viku samfara
einkennum s.s. uppembu og verkjum. Orsakir fyrir hgatregu eru margvslegar.
Algengar orsakir hgatregu eru kyrrseta, trefjasnautt fi og ltil vkvaneysla, en einnig
rskun venjum t.d. vi feralg. Hgatrega getur einnig veri aukaverkun lyfja, t.d. valda verkjalyf sem innihalda kdein ea morfn, hgatregu. Mrg nnur lyf koma einnig til greina.
Hgalyf geta t.d. valdi hgatregu ef au eru misnotu. Vi mefer hgatregu er
hfuhersla vallt lg fyrirbyggjandi agerir, ar sem reglubundi lferni, dagleg
vatnsdrykkja, trefjark fa og hfileg hreyfing eru aalatrii.


Lyfjaval

Eingngu fyrir sem  geta drukki ng vatn og eldra flk sem  ekki er rmfast

Rmmlsaukandi lyf (A 06 AC)

Semen Psyllii t.d. HUSK: 1 matskei dag me a.m.k. einu glasi af vatni.


Ef essi mefer virkar ekki ea olist illa m reyna, ea bta vi

Hgalyfi me osmtska verkun (A 06 AD)

Sorbitol mixtra

Laktlsa mixtra 15 - 30 ml senn allt a 4 sinnum dag.

og/ea

Lyf sem eykur armahreyfingar (A 06AB)

Senna, t.d. Senokot 1-2 tflur a kvldi 3svar viku.

Takmarka ber mefer me Senna lyfjum vi fyrirfram kveinn tma.

 

Tv sastnefndu lyfin eru notu vi mefer hgatregu hj eldra
flki sem er ori lasbura og ekki er tryggt a drekki ng af vatni.

er mefer hafin me M. Sorbitol og Senna btt vi ef arf.


Ef rembingur er hfuvandaml og erfileikar eru a koma hgum fr sr er hgt a nota,
auk ofangreindra lyfja.

Bsakdl endaarmsstla t.d. Dulcolax, einn stl a morgni eftir morgunver, mest 3svar viku.


Athugasemdir

byrjun getur urft a losa um hgir me reifingu hj einstaklingum me langvinna hgatregu
og uppsfnun hga endaarmi og ristli. er losun hga me rektal reifingu fylgt eftir me:

Innhellislyfjum (A 06AG), en au eru einnig notu til a tma arma fyrir rntgenskoanir ea
skuragerir.

Biskdl - Toilax, Dkusat natrum - Klyx ea Lrlslfat - Mcrolax


Heimildir

  1. Effectiveness of laxatives in adults University of York. NHS Centre for Reviews and Dissemination. Effectiveness of laxatives in adults..Effective Health Care 7(1): 12.
  2. Systematic review of the effectiveness of laxatives in the elderly. Petticrew M, Watt I, Sheldon T. Health Technology Assessment Vol.1: No.13 1997: 1(13) 53.
  3. SM Tramonte, NB Brand, CD Mulrow et al. The treatment of chronic constipation: a systematic review. Journal of General Internal Medicine 1997 12: 15-24.
  4. Locke GR, Pemberton JH, Phillips SF. American Gastroenterological Association medical position statement: guidelines on constipation. Gastroenterology 2000 Dec;119(6):1761-6.
  5. MeReC 1999; vol 190 no 9. "The management of constipation" http://www.npc.co.uk/
  6. Donatelle EP. Constipation: Pathophysiology and treatment. Am Fam Physician 1990;42:1335-1342
  7. Harari D, Gurwitz JH, Minaker KL. Constipation in the elderly. JAm Geriatr Soc 1993;41:1130-1140
  8. Cheskin LJ, Kamal N, Crowell MD, Schuster MM, Whitehead WE.
  9. Mechanisms of constipation in older persons and effects of fiber compared with placebo. J Am Geriatr Soc 1995;43:666-669
  10. Kot TV, Pettit-Young NA. Lactulose in the management of constipation: a current review. Ann Pharmacother 1992;26:1277-1282
  11. Passmore AP, Wilson-Davies K, Stoker C, Scott ME. Chronicconstipation in long stay elderly patients: a comparison of lactulose and a senna-fibre combination. BMJ 1993;307:769-771
  12. Puxty JAH, Fox RA. Golytely: a new approach to faecal impaction in old age. Age and Ageing 1986;15:182-184
  13. Harari D. et al. Correlates of Regular Laxative Use by Frail Elderly Persons. Am.J.of Med.1995;99(5):513-518.

Unni 1998 af Jni E Jnssyni, Einari Magnssyni og Siguri Helgasyni og endurskoa 1999 af Ingolf Pedersen og Siguri Helgasyni.

Fr ritstjra:

Nleg ttekt mefer vi hgatregu megngu vegum Cochrane samtakanna sndi a trefjar hefu gagnleg hrif. Jewell DJ, Young G. Interventions for treating constipation in pregnancy (Cochrane Review). In: The Cochrane Library, Issue 1, 2003. Oxford: Update Software. http://www.update-software.com/abstracts/ab001142.htm

Endurskoðað í apríl 2003. Sigurður Helgason